scispace - formally typeset
L

Lamberto Manzoli

Researcher at University of Ferrara

Publications -  271
Citations -  9694

Lamberto Manzoli is an academic researcher from University of Ferrara. The author has contributed to research in topics: Population & Randomized controlled trial. The author has an hindex of 49, co-authored 260 publications receiving 7667 citations. Previous affiliations of Lamberto Manzoli include American Board of Legal Medicine & University Hospital of North Norway.

Papers
More filters
Journal ArticleDOI

Marital status and mortality in the elderly: a systematic review and meta-analysis.

TL;DR: An overall estimate of the excess mortality associated with being unmarried in aged individuals as well as to evaluate whether and to what degree the effect of marriage differs with respect to gender, geographical/cultural context, type of non-married condition and study methodological quality are produced.

Guidelines for safe recreational water environments.Volume 1, coastal and fresh water

TL;DR: The World Health Organization's (WHO) new Guidelines for Safe Recreational Water Environments describes the present state of knowledge regarding the impact of recreational use of coastal and freshwater environments upon the health of users.
Journal ArticleDOI

Prenatal identification of invasive placentation using magnetic resonance imaging: systematic review and meta-analysis.

TL;DR: To assess systematically the performance of prenatal magnetic resonance imaging in diagnosing the presence, degree and topography of disorders of invasive placentation and to explore the role of the different MRI signs in predicting these disorders.
Journal ArticleDOI

Polycystic ovary syndrome is a risk factor for type 2 diabetes: results from a long-term prospective study.

TL;DR: It is demonstrated that the risk of type 2 diabetes is markedly elevated in middle-aged women with PCOS and suggests including BMI, glucose, and SHBG-circulating levels in the risk stratification.
Journal ArticleDOI

Peppermint oil (Mintoil) in the treatment of irritable bowel syndrome: a prospective double blind placebo-controlled randomized trial.

TL;DR: A 4 weeks treatment with peppermint oil improves abdominal symptoms in patients with irritable bowel syndrome.